Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
VRN Stock Forecast 2025-2026
$6.01
Current Price
$3.69B
Market Cap
Buy 5
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to VRN Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
VRN Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
+13.8%
1 Year Change
+16.9%
Year-to-Date Change
-34.2%
From 52W High of $9.14
+36.9%
From 52W Low of $4.39
📊 TOP ANALYST CALLS
Did VRN Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Veren is one of their latest high-conviction picks.
Latest VRN Stock Price Targets & Analyst Predictions
VRN has shown a year-to-date change of 16.9% and a 1-year change of 13.8%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for VRN. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
VRN Analyst Ratings
5
Buy
0
Hold
0
Sell
VRN Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $6.01
Latest VRN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for VRN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 1, 2024 | RBC Capital | Michael Harvey | Outperform | Maintains | $10.00 |
| Oct 18, 2024 | Raymond James | Luke Davis | Strong Buy | Initiates | $13.00 |
| Jul 12, 2024 | Scotiabank | Sector Outperform | Maintains | $15.00 |
Veren Inc. (VRN) Competitors
The following stocks are similar to Veren based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Veren Inc. (VRN) Financial Data
Veren Inc. has a market capitalization of $3.69B with a P/E ratio of 18.2x. The company generates $2.91B in trailing twelve-month revenue with a 6.9% profit margin.
Revenue growth is +5.6% quarter-over-quarter, while maintaining an operating margin of +15.1% and return on equity of +4.2%.
Valuation Metrics
Market Cap
$3.69B
Enterprise Value
$4.93B
P/E Ratio
18.2x
PEG Ratio
7.9x
Price/Sales
0.9x
Growth & Margins
Revenue Growth (YoY)
+5.6%
Gross Margin
+55.0%
Operating Margin
+15.1%
Net Margin
+6.9%
EPS Growth
+12.2%
Financial Health
Cash/Price Ratio
+0.5%
Current Ratio
0.6x
Debt/Equity
45.3x
ROE
+4.2%
ROA
+3.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Veren Inc. (VRN) Business Model
About Veren Inc.
What They Do
Develops innovative therapies for unmet medical needs.
Business Model
Veren Inc. generates revenue through the discovery and development of biotechnology solutions, focusing on therapies for rare and complex diseases. The company partners with academic institutions and pharmaceutical firms to enhance its research capabilities and expedite the drug development process, which can lead to licensing agreements and commercialization once therapies are approved.
Additional Information
Veren Inc. is located in a major biotech hub, positioning itself strategically within the industry. Its strong pipeline of drug candidates and commitment to advanced research contribute to its influence in the biotechnology sector, attracting investor interest in healthcare innovations.
Company Information
Sector
Energy
Industry
Oil & Gas E&P
Employees
746
CEO
Mr. Craig Bryksa
Country
Canada
IPO Year
2003
Website
www.vrn.comVeren Inc. (VRN) Latest News & Analysis
Latest News
WHITECAP RESOURCES INC. AND VEREN INC.
6 months ago
Quick Summary
Whitecap Resources Inc. will acquire Veren Inc. following a court approval of their business combination. Veren shareholders will receive 1.05 Whitecap shares for each Veren share held.
Why It Matters
The court's approval of Whitecap's acquisition of Veren indicates a significant consolidation in the energy sector, potentially impacting stock valuations and market dynamics for both companies.
Source: PRNewsWire
Market Sentiment:
Neutral
Wall Street Analysts Think Veren (VRN) Could Surge 34.97%: Read This Before Placing a Bet
6 months ago
Quick Summary
Wall Street analysts project a 35% upside for Veren (VRN), supported by positive earnings estimate revisions, despite some skepticism about the reliability of price targets.
Why It Matters
Wall Street analysts see a 35% upside for Veren (VRN), suggesting potential for significant gains. Positive earnings revisions further enhance bullish sentiment around the stock.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Veren (VRN) is expected to report strong earnings, possessing key factors that suggest a likely earnings beat in its upcoming report.
Why It Matters
Veren's potential earnings beat may signal strong financial performance, positively influencing stock price and investor sentiment, indicating growth prospects and confidence in management.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
An investor has shifted from oil stocks to Whitecap Resources, citing a strong merger with Veren, solid Q1 results, and a sustainable 9% dividend yield due to reduced breakeven costs.
Why It Matters
The focus on Whitecap's strong Q1 results, merger synergies, and sustainable dividend yield signals confidence in resilience and profitability, potentially attracting more investor interest in the stock.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Investors may consider SLB, IMO, and VRN as potential dividend stocks to watch for 2025.
Why It Matters
The mention of SLB, IMO, and VRN highlights potential opportunities for income through dividends, indicating stability and growth prospects that could attract investors in 2025.
Source: Zacks Investment Research
Market Sentiment:
Positive
Wall Street Analysts See a 27.59% Upside in Veren (VRN): Can the Stock Really Move This High?
7 months ago
Quick Summary
Wall Street analysts project a 27.6% upside for Veren (VRN), supported by positive earnings estimate revisions.
Why It Matters
A 27.6% potential upside in Veren (VRN) price targets suggests significant growth, and positive earnings estimate revisions may further enhance investor confidence and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About VRN Stock
What is Veren Inc.'s (VRN) stock forecast for 2026?
Analyst forecasts for Veren Inc. (VRN) are not currently available. The stock is trading at $6.01.
Is VRN stock a good investment in 2026?
According to current analyst ratings, VRN has 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $6.01. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for VRN stock?
Price predictions from Wall Street analysts for VRN are not currently available. The stock is trading at $6.01.
What is Veren Inc.'s business model?
Veren Inc. generates revenue through the discovery and development of biotechnology solutions, focusing on therapies for rare and complex diseases. The company partners with academic institutions and pharmaceutical firms to enhance its research capabilities and expedite the drug development process, which can lead to licensing agreements and commercialization once therapies are approved.
What is the highest forecasted price for VRN Veren Inc.?
Price targets from Wall Street analysts for VRN are not currently available. The stock is trading at $6.01.
What is the lowest forecasted price for VRN Veren Inc.?
Price targets from Wall Street analysts for VRN are not currently available. The stock is trading at $6.01.
What is the overall VRN consensus from analysts for Veren Inc.?
The overall analyst consensus for VRN is bullish. Out of 3 Wall Street analysts, 5 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are VRN stock price projections?
Stock price projections, including those for Veren Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 4, 2025 11:56 PM UTC